West Pharmaceutical Services (NYSE:WST – Get Free Report) and Autonomix Medical (NASDAQ:AMIX – Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, dividends and profitability.
Risk and Volatility
West Pharmaceutical Services has a beta of 1.15, indicating that its stock price is 15% more volatile than the S&P 500. Comparatively, Autonomix Medical has a beta of -1.16, indicating that its stock price is 216% less volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent recommendations for West Pharmaceutical Services and Autonomix Medical, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| West Pharmaceutical Services | 0 | 3 | 11 | 1 | 2.87 |
| Autonomix Medical | 1 | 1 | 1 | 0 | 2.00 |
Insider & Institutional Ownership
93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by insiders. Comparatively, 6.2% of Autonomix Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares West Pharmaceutical Services and Autonomix Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| West Pharmaceutical Services | 16.98% | 20.11% | 14.83% |
| Autonomix Medical | N/A | -267.73% | -216.75% |
Earnings and Valuation
This table compares West Pharmaceutical Services and Autonomix Medical”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| West Pharmaceutical Services | $3.07 billion | 7.93 | $493.70 million | $7.81 | 44.33 |
| Autonomix Medical | N/A | N/A | -$16.72 million | ($59.03) | -0.10 |
West Pharmaceutical Services has higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.
Summary
West Pharmaceutical Services beats Autonomix Medical on 12 of the 14 factors compared between the two stocks.
About West Pharmaceutical Services
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
About Autonomix Medical
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.
